Authors showcase the use of mass spectrometry to establish quality control attributes in GMP-produced spiN antigen, suggesting enhanced reliability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Brant et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: